PCI The Journeys Within

Current Edition

Frankfurt 2027 – 12/10/26
ramusmedical
news

PCI Announces Expansion of High Potent Tableting and Powder Modification Capacity

Investment in new technologies at PCI’s global manufacturing Center of Excellence in Tredegar, Wales, to double highly potent tableting capacity and boost powder han...
Continue Reading →
news

PCI Pharma Services Appoints New Chief Financial Officer, SVP, Serge Dupuis

Philadelphia, PA – 22 March, 2019. Leading global biopharmaceutical outsourcing services provider PCI Pharma Services (PCI) is pleased to welcome Serge Dupuis as Sen...
Continue Reading →
news

Researchers report promising results of potential reversal agent

In patients with acute coronary syndromes, coronary artery stenting, or a history of prior heart attacks, antiplatelet therapy can be lifesaving. Ticagrelor, in comb...
Continue Reading →
news

Apple heart study: Early proof of concept, or a bit of a gimmick?

Preliminary results in a study of Apple Watch's ability to track heart data found 0.5%, or 2,161 people, received notifications of a potential irregular heartbeat an...
Continue Reading →
news

Lilly’s Cyramza comes up positive in first-line lung cancer trial

Eli Lilly's anti-angiogenic therapy Cyramza met the primary endpoint of a late-stage study, improving progression-free survival in previously untreated patients with...
Continue Reading →
news

Tecentriq assumes pole position with FDA approval but Keytruda looms in triple negative breast cancer, says GlobalData

On March 8, the FDA granted the accelerated approval of Roche’s programmed cell death protein 1 (PD-1) inhibitor Tecentriq in combination with Abraxane (protein-boun...
Continue Reading →
Europe

Praluent® (alirocumab) now approved in European Union to reduce the risk of cardiovascular events in patients with established cardiovascular disease

Approval is based on ODYSSEY OUTCOMES trial of 18,924 patients who recently suffered an acute coronary syndrome such as a heart attackPraluent is the only EU-approve...
Continue Reading →
news

Ardelyx’s Tenapanor may be answer to growing demand for novel CKD-MBD treatments, says GlobalData

Even though the chronic kidney disease–mineral bone disorder (CKD-MBD) market is set to face several barriers to growth over the next decade, the anticipated launch ...
Continue Reading →
Europe

SOTIO’s DCVAC/OvCa Significantly Improves Survival in Patients with Recurrent Ovarian Cancer

DCVAC/OvCa decreased the risk of death in second line treatment of ovarian cancer by 62%Overall survival (OS) increased significantly by 13.4 months. Median Pro...
Continue Reading →
Europe

Life Sciences Companies Adopt Veeva Nitro to Eliminate the Burden of Custom Data Warehouse Development and Maintenance

Next-generation commercial data warehouse speeds implementation and automatically syncs with most important data sources BARCELONA, Spain — 19 March 2019—Veeva Sys...
Continue Reading →
Quotient